Provided by Tiger Trade Technology Pte. Ltd.

AbCellera Biologics

12.64
+0.09000.72%
Pre-market: 12.60-0.0350-0.28%08:17 EDT
Volume:5.76M
Turnover:73.30M
Market Cap:4.09B
PE:-23.16
High:13.06
Open:12.71
Low:12.43
Close:12.55
52wk High:15.02
52wk Low:2.75
Shares:324.00M
Float Shares:221.00M
Volume Ratio:0.90
T/O Rate:2.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5455
EPS(LYR):-0.4902
ROE:-17.30%
ROA:-10.39%
PB:4.57
PE(LYR):-25.78

Loading ...

After AbCellera Biologics' 125% Climb, The Story Has Changed

Simply Wall St.
·
5 hours ago

AbCellera Biologics' ABCL635 Seen With Best-in-Class Potential in Menopause, UBS Says

MT Newswires Live
·
19 hours ago

AbCellera Biologics Initiated at Buy by UBS

Dow Jones
·
Yesterday

UBS Initiates AbCellera Biologics at Buy With $18 Price Target

MT Newswires Live
·
Yesterday

AbCellera initiated with a Buy at UBS

TIPRANKS
·
Yesterday

AbCellera to Present Phase 1/2 ABCL635 Data at Menopause Society Meeting

MT Newswires Live
·
Oct 09

AbCellera to present Phase 1/2 data for ABCL635 at TMS 2026 Annual Meeting

TIPRANKS
·
Oct 09

Press Release: AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026

Dow Jones
·
Oct 02

AbCellera Schedules Quarterly Results Release, Earnings Call

Reuters
·
Oct 02

AbCellera Biologics call volume above normal and directionally bullish

TIPRANKS
·
Sep 30

JPMorgan Initiates AbCellera Biologics at Overweight With $17 Price Target

MT Newswires Live
·
Sep 29

Abcellera Biologics Inc. : JP Morgan Initiates Coverage with Overweight Rating; Target Price $17

THOMSON REUTERS
·
Sep 29

JonesTrading Sticks to Their Buy Rating for AbCellera Biologics (ABCL)

TIPRANKS
·
Sep 28

AbCellera Biologics Price Target Announced at $13.00/Share by Goldman Sachs

Dow Jones
·
Sep 24

AbCellera Biologics (ABCL) Receives a Hold from Goldman Sachs

TIPRANKS
·
Sep 24

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 21

AbCellera Biologics call volume above normal and directionally bullish

TIPRANKS
·
Sep 17

AbCellera to present Phase 2 Data for ABCL635 at IMS Congress on Menopause

TIPRANKS
·
Sep 17

AbCellera to Present Phase 2 Abcl635 Data for Menopause Hot Flashes at IMS World Congress 2026

Reuters
·
Sep 17

AbCellera Biologics call volume above normal and directionally bullish

TIPRANKS
·
Sep 16